Advancing the Care of Patients With Type 2 Diabetes and Chronic Kidney Disease: Role of the Glucagon-Like Peptide-1 Receptor Agonists

To participate in this activity, please:

The care of patients with type 2 diabetes and chronic kidney disease requires a multidisciplinary approach; hence, this activity takes a multidisciplinary approach to educate clinicians of various disciplines. Nephrologist and clinical trialist George Bakris, MD, reviews the burden of diabetic kidney disease (DKD) and provides guideline recommendations to properly screen and prevent cardiovascular disease events in patients with DKD. Fellow clinical trialist and diabetes expert John Buse, MD, PhD, discusses the pharmacology and prescribing considerations of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and highlights this class while reviewing new consensus reports. Dr. Buse teams up with Dr. Bakris to discuss the cardiorenal benefits of GLP-1 RAs evidenced by cardiovascular outcomes trials and recent meta-analyses. Primary care and internal medicine specialist John Anderson, MD, joins Drs. Bakris and Buse to lead the discussion of 2 cases of patients with DKD. Dr. Anderson concludes by discussing the importance of multidisciplinary management in optimizing care for our patients with type 2 diabetes and chronic kidney disease.

This program is also available as a podcast. You may download it here:https://anchor.fm/t2d-ckd

Course Credit:

1.5 ACPE Contact Hours
1.5 AMA PRA Category 1 CreditsTM
1.5 ANCC Contact Hours
1.5 CA-BRN Contact Hours
1 Pharmacology Hour

Dates:

Opens: 2023-02-06
Closes: 2024-02-06

Target Audience:

This activity was developed for nephrologists, endocrinologists, family physicians, physician assistants, nurse practitioners, pharmacists and other clinicians interested in the prevention and management of nephropathy in patients with type 2 diabetes.

This activity is supported by an independent educational grant from Novo Nordisk Inc.

    Presenting Faculty

  • John E. Anderson, MD

    Internal Medicine and Diabetes
    The Frist Clinic
    Nashville, Tennessee

  • George Bakris, MD

    Professor of Medicine
    Director, American Heart Association Comprehensive Hypertension Center
    University of Chicago Medicine
    Chicago, Illinois

  • John B. Buse, MD, PhD

    Verne S. Caviness Distinguished Professor
    Director, Diabetes Center
    Director, NC Translational and Clinical Sciences Institute
    Senior Associate Dean, Clinical Research
    University of North Carolina School of Medicine
    Chapel Hill, North Carolina